This observation was also consistent with the GL261nectin1 GBM model where treatment with two different oHSVs (rQNestin34.5 or NG34) decreased PD-1 levels in CD8+ co-localized clusters in an unbiased analysis (Fig. 3, i). The gene discussed is CD8A; the disease is glioblastoma.